Accelerated axon loss in MOG35-55 experimental autoimmune encephalomyelitis (EAE) in myelin-associated glycoprotein-deficient (MAGKO) mice

Journal of Neuroimmunology

Volumn 262, Issue 1-2, 2013, Pages 53-61

  Jones, Melina V ^a   Nguyen, Thien T ^a   Ewaleifoh, Osefame ^a   Lebson, Lori ^a   Whartenby, Katherine A ^a   Griffin, John W ^a,b   Calabresi, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Neuroscience ^*  (United States)

Author keywords

B4galnt1KO; EAE; MAG; Microglia; T cell; Timeline

Indexed keywords

CD3 ANTIGEN; DEXAMETHASONE; MYELIN ASSOCIATED GLYCOPROTEIN; PEPTIDES AND PROTEINS; PROTEIN IBA 1; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOREACTIVITY; INFLAMMATORY CELL; KNOCKOUT MOUSE; MICROGLIA; MONOCYTE; MOUSE; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WILD TYPE;

B4GALNT1KO; EAE; MAG; MICROGLIA; T CELL; TIMELINE;

ANIMALS; AXONS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MALE; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MYELIN-ASSOCIATED GLYCOPROTEIN; TIME FACTORS;

EID: 84884166115     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.06.008     Document Type: Article

References (47)

1. Aguayo A.J., David S., Bray G.M. Influences of the glial environment on the elongation of axons after injury: transplantation studies in adult rodents. J. Exp. Biol. 1981, 95:231-240.
2. Atwal J.K., Pinkston-Gosse J., Syken J., Stawicki S., Wu Y., Shatz C., Tessier-Lavigne M. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008, 322:967-970.
3. Budde M.D., Xie M., Cross A.H., Song S.K. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. J. Neurosci. 2009, 29:2805-2813.
4. Cao Z., Gao Y., Deng K., Williams G., Doherty P., Walsh F.S. Receptors for myelin inhibitors: structures and therapeutic opportunities. Mol. Cell. Neurosci. 2010, 43:1-14.
5. Dashiell S.M., Tanner S.L., Pant H.C., Quarles R.H. Myelin-associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases. J. Neurochem. 2002, 81:1263-1272.
6. DeBoy C.A., Zhang J., Dike S., Shats I., Jones M., Reich D.S., Mori S., Nguyen T., Rothstein B., Miller R.H., Griffin J.T., Kerr D.A., Calabresi P.A. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 2007, 130:2199-2210.
7. Domeniconi M., Cao Z., Spencer T., Sivasankaran R., Wang K., Nikulina E., Kimura N., Cai H., Deng K., Gao Y., He Z., Filbin M. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 2002, 35:283-290.
8. Donia M., Mangano K., Quattrocchi C., Fagone P., Signorelli S., Magro G., Sfacteria A., Bendtzen K., Nicoletti F. Specific and strain-independent effects of dexamethasone in the prevention and treatment of experimental autoimmune encephalomyelitis in rodents. Scand. J. Immunol. 2010, 72:396-407.
9. Dumser M., Bauer J., Lassmann H., Berger J., Forss-Petter S. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency. Acta Neuropathol. 2007, 114:573-586.
10. Fry E.J., Ho C., David S. A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron 2007, 53:649-662.
11. Garthwaite G., Batchelor A.M., Goodwin D.A., Hewson A.K., Leeming K., Ahmed Z., Cuzner M.L., Garthwaite J. Pathological implications of iNOS expression in central white matter: an ex vivo study of optic nerves from rats with experimental allergic encephalomyelitis. Eur. J. Neurosci. 2005, 21:2127-2135.
12. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., Samokhvalov I.M., Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
13. Heneka M.T., O'Banion M.K., Terwel D., Kummer M.P. Neuroinflammatory processes in Alzheimer's disease. J. Neural Transm. 2010, 117:919-947.
14. Howell O.W., Rundle J.L., Garg A., Komada M., Brophy P.J., Reynolds R. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J. Neuropathol. Exp. Neurol. 2010, 69:1017-1033.
15. Jones M.V., Calabresi P.A. Agar-gelatin for embedding tissues prior to paraffin processing. Biotechniques 2007, 42:569-570.
16. Jones M.V., Nguyen T.T., Deboy C.A., Griffin J.W., Whartenby K.A., Kerr D.A., Calabresi P.A. Behavioral and pathological outcomes in MOG35-55 experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2008, 199:83-93.
17. Jung A.P., Curtis T.S., Turner M.J., Lightfoot J.T. Physical activity and food consumption in high- and low-active inbred mouse strains. Med. Sci. Sports Exerc. 2010, 42:1826-1833.
18. Liu B. Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J. 2006, 8:E606-E621.
19. Lo A.C., Saab C.Y., Black J.A., Waxman S.G. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol. 2003, 90:3566-3571.
20. Loers G., Aboul-Enein F., Bartsch U., Lassmann H., Schachner M. Comparison of myelin, axon, lipid, and immunopathology in the central nervous system of differentially myelin-compromised mutant mice: a morphological and biochemical study. Mol. Cell. Neurosci. 2004, 27:175-189.
21. Maezawa I., Zimin P., Wulff H., Jin L.W. A{beta} oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J. Biol. Chem. 2011, 286(5):3693-3706. 10.1074/jbc.M110.135244.
22. Nakamura Y., Fujita Y., Ueno M., Takai T., Yamashita T. Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury. J. Biol. Chem. 2011, 286:1876-1883.
23. Nguyen T., Mehta N.R., Conant K., Kim K.J., Jones M., Calabresi P.A., Melli G., Hoke A., Schnaar R.L., Ming G.L., Song H., Keswani S.C., Griffin J.W. Axonal protective effects of the myelin-associated glycoprotein. J. Neurosci. 2009, 29:630-637.
24. Omiya Y., Goto K., Suzuki Y., Ishige A., Komatsu Y. Analgesia-producing mechanism of processed Aconiti tuber: role of dynorphin, an endogenous kappa-opioid ligand, in the rodent spinal cord. Jpn. J. Pharmacol. 1999, 79:295-301.
25. Pan B., Fromholt S.E., Hess E.J., Crawford T.O., Griffin J.W., Sheikh K.A., Schnaar R.L. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol. 2005, 195:208-217.
26. Rasmussen S., Wang Y., Kivisakk P., Bronson R.T., Meyer M., Imitola J., Khoury S.J. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing-remitting experimental autoimmune encephalomyelitis. Brain 2007, 130:2816-2829.
27. Richardson P.M., Issa V.M., Aguayo A.J. Regeneration of long spinal axons in the rat. J. Neurocytol. 1984, 13:165-182.
28. Rostasy K.M. Inflammation and neuroaxonal injury in multiple sclerosis and AIDS dementia complex: implications for neuroprotective treatment. Neuropediatrics 2005, 36:230-239.
29. Saederup N., Cardona A.E., Croft K., Mizutani M., Cotleur A.C., Tsou C.L., Ransohoff R.M., Charo I.F. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One 2010, 5:e13693.
30. Sanders P., De Keyser J. Janus faces of microglia in multiple sclerosis. Brain Res. Rev. 2007, 54:274-285.
31. Sawada M., Sawada H., Nagatsu T. Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases. Neurodegener Dis. 2008, 5:254-256.
32. Schnaar R.L., Lopez P.H. Myelin-associated glycoprotein and its axonal receptors. J. Neurosci. Res. 2009, 87:3267-3276.
33. Sheikh K.A., Sun J., Liu Y., Kawai H., Crawford T.O., Proia R.L., Griffin J.W., Schnaar R.L. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7532-7537.
34. Skarica M., Wang T., McCadden E., Kardian D., Calabresi P.A., Small D., Whartenby K.A. Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis. J. Immunol. 2009, 182:4192-4199.
35. Sugama S., Takenouchi T., Cho B.P., Joh T.H., Hashimoto M., Kitani H. Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflamm. Allergy Drug Targets 2009, 8:277-284.
36. Sun J., Shaper N.L., Itonori S., Heffer-Lauc M., Sheikh K.A., Schnaar R.L. Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides. Glycobiology 2004, 14:851-857.
37. Teng F.Y., Tang B.L. Why do Nogo/Nogo-66 receptor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents?. J. Neurochem. 2005, 94:865-874.
38. Trapp B.D., Andrews S.B., Cootauco C., Quarles R. The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J. Cell Biol. 1989, 109:2417-2426.
39. Trapp B.D., Ransohoff R., Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 1999, 12:295-302.
40. Ujike A., Takeda K., Nakamura A., Ebihara S., Akiyama K., Takai T. Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. Nat. Immunol. 2002, 3:542-548.
41. Weiss M.D., Luciano C.A., Quarles R.H. Nerve conduction abnormalities in aging mice deficient for myelin-associated glycoprotein. Muscle Nerve. 2001, 24:1380-1387.
42. Witschi H., Espiritu I., Uyeminami D. Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone. Carcinogenesis 1999, 20:1375-1378.
43. Wujek J.R., Bjartmar C., Richer E., Ransohoff R.M., Yu M., Tuohy V.K., Trapp B.D. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol. 2002, 61:23-32.
44. Xu J., Sun S.W., Naismith R.T., Snyder A.Z., Cross A.H., Song S.K. Assessing optic nerve pathology with diffusion MRI: from mouse to human. NMR Biomed. 2008, 21:928-940.
45. Yadav A., Collman R.G. CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J. Neuroimmune Pharmacol. 2009, 4:430-447.
46. Zhang J., Jones M., DeBoy C.A., Reich D.S., Farrell J.A., Hoffman P.N., Griffin J.W., Sheikh K.A., Miller M.I., Mori S., Calabresi P.A. Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy. J. Neurosci. 2009, 29:3160-3171.
47. Zhang J., Aggarwal M., Mori S. Structural insights into the rodent CNS via diffusion tensor imaging. Trends Neurosci. 2012, 35:412-421.